ACCUMED News

EDI Novel Coronavirus COVID-19 IgG & IgM ELISA Kits

20th April 2020

AccuMed, in collaboration with Epitope Diagnostics, has proudly introduced immunoassay kits exclusively for the qualitative detection of COVID-19 IgG and IgM in human serum. With proven results from clinical testing in China, Epitope Diagnostics is eager to co-operate and collaborate to combat the current COVID-19 situation.

For more information, click here!

MutaPLEX® Coronavirus (SARS-CoV-2) RT-PCR kit (catalogue# KG192696)

18th March 2020

AccuMed would like to announce that, in conjunction with our partners Immundiagnostik GmBH (IDK, based in Bensheim Germany), we can offer you the most advanced Coronavirus RT-PCR test kit available.
The MutaPLEX® Coronavirus (SARS-CoV-2) RT-PCR kit is CE-marked and is available for shipping from 19th March. The kit has been designed for use on open Real-Time PCR instruments with FAM, HEX, CY5, and ROX detection channels (see pages 8-10 of the link below), and is shipped on dry ice or ice packs.

For more information, click here!

AccuMed introduces IDKmonitor Therapeutic Drug Monitoring ELISA’s to the diagnostic marketplace

IDKmonitor TDM ELISA’s from Immundiagnostik provide precise Drug Level measurements as well as Anti-Drug Antibody (ADA) detection from a single blood sample. Clinical applications for the management of inflammatory conditions such as inflammatory bowel disease (IBD) include:

  • • Predict and/or manage loss of response
  • • Inform treatment decisions
  • • Investigate adherence
  • • Assessment prior to stopping/restarting therapy


For further information please contact Jim Woods or Pat Kerley at +353 (0)1 8537320 or email info@accumed.ie
https://www.biohithealthcare.co.uk/assays-for-tdm-in-ibd

AccuMed introduces Peptest to the diagnostic marketplace in Ireland.

Peptest is a simple, effective and low cost test that tells you conclusively that a patient has reflux. By measuring pepsin in saliva samples, this is a clear indicator that a reflex episode has occurred because pepsin is only produced in the stomach. If it is detected in the oesophagus, throat, mouth or lungs it identifies reflux and enables a swift and appropriate treatment plan to be made.

https://www.biohithealthcare.co.uk/Diagnostics/Item/Peptest-50-tests

QuantOn Cal, a test system for the quantitative determination of calprotectin in faeces, is now available from AccuMed.

QuantOn Cal consists of a rapid lateral flow test that detects human calprotectin, and a smartphone app that analyses the result of the rapid test quantitatively based on the colour intensity of the control and test lines. Results are automatically emailed to the patient’s doctor and are logged in the Doctor’s Online Portal. The test system is an in-vitro diagnostic device (IVD) intended for self-testing at home, and individual monitoring of treatment efficacy for patients with chronic inflammatory bowel disease (IBD).

https://www.biohithealthcare.co.uk/quantoncal

Analyse your patient’s microbiota with the GA-Map Dysbiosis Test Lx, now available from AccuMed.

The GA-Map dysbiosis test Lx is the first CE-marked gut microbiota DNA analysis tool to identify and characterise dysbiosis from a faecal sample. This test provides a rapid, high-throughput analysis of a large number of individual faecal samples and provides a standardised approach to microbiota analysis.

https://www.biohithealthcare.co.uk/Diagnostics/Item/GA-Map